Journals / Türk Kardiyoloji Derneği Arşivi / 2010 / Cilt: 38 - Sayı: 4

Anabolik steroid kullanan vücut geliştirme sporcusunda akut miyokart enfarktüsü ve renal enfarktüs

Acute myocardial infarction and renal infarction in a bodybuilder using anabolic steroids

Pages
275–278
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Intensive coronary artery and left ventricular thrombi may be explained by the use of anabolic steroids.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 41-year-old male bodybuilder was admitted with acute inferior myocardial infarction.
📊
Key Findings & Data:The patient had been using oxymetholone and methenolone to increase his performance for 15 years and quitted smoking three years before.
💡
Conclusion & Impact:Intensive coronary artery and left ventricular thrombi may be explained by the use of anabolic steroids.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 41-year-old male bodybuilder was admitted with acute inferior myocardial infarction. The patient had been using oxymetholone and methenolone to increase his performance for 15 years and quitted smoking three years before. He underwent successful primary percutaneous coronary intervention (PCI) and bare metal stenting for total occlusion of the proximal right coronary artery. Angiography also showed a critical lesion in the left anterior descending (LAD) coronary artery. Five hours after primary PCI, the patient had severe right flank pain. Abdominal computed tomography showed a large renal infarction in the right kidney. Subcutaneous enoxaparin was added to dual antiplatelet treatment. Doppler renal ultrasound performed on the eighth day showed findings of reperfusion in the right kidney and normal-size kidneys. Transthoracic echocardiography demonstrated disappearance of previously detected thrombus remnant in the left ventricle and only mild hypokinesia around the apical and middle segments of the inferior and inferoseptal walls. The patient was discharged on the 10th day. Renal arteriography during elective LAD intervention 18 days after discharge showed complete revascularization, stent patency, and improved blood flow. This is the first case of renal infarction that developed in the early hours of primary PCI, despite effective anticoagulant and antiplatelet treatment. Intensive coronary artery and left ventricular thrombi may be explained by the use of anabolic steroids.

Özet

Kırk bir yaşında, vücut geliştirme sporcusu erkek hasta akut inferiyor miyokart enfarktüsü tanısıyla yatırıldı. Hasta performansını artırmak için 15 yıldır oksimetolon ve metenolon kullanmaktaydı ve sigarayı bırakalı üç yıl olmuştu. Hastaya başarılı primer perkütan koroner girişimle (PKG) proksimal sağ koroner arterdeki tam tıkanıklık için çıplak metal stent takıldı. Anjiyografide sol ön inen koroner arterde de kritik lezyon saptandı.Primer PKG’den beş saat sonra hastada şiddetli sağ böğür ağrısı gelişti. Abdominal bilgisayarlı tomografide geniş sağ renal enfarktüs saptandı. İkili antitrombosit tedavisine enoksaparin eklenen hastada sekizinci günde yapılan renal Doppler ultrasonografide sağ böbrekte reperfüzyon bulguları izlendi ve her iki böbrek de normal büyüklükte bulundu. Transtorasik ekokardiyografide sol ventriküldeki trombüs kalıntısının kaybolduğu, inferiyor ve inferoseptal duvarların apikal ve orta segmentlerinde hafif hipokinezi olduğu görüldü. Onuncu günde taburcu edilen hastaya, taburculuğundan 18 gün sonra, sol ön inen artere yönelik elektif girişim sırasında yapılan renal arteriyografide tam revaskülarizasyon görüldü, stent açıktı ve kan akımı düzelmişti. Sunulan olgu, primer PKG sonrası erken saatlerde, güçlü antikoagülan ve antitrombosit tedaviye rağmen renal enfarktüs geliştiği bildiren ilk olgudur. Hastanın kullanmakta olduğu anabolik steroidlerin yoğun koroner ve sol ventriküldeki trombüs yüküne neden olduğu düşünüldü.

🔖

Cite This Article

DEMİRCİ, D., İLHAN, E., ÇALIK, A. N., GÜVENÇ, T. S. (2022). Anabolik steroid kullanan vücut geliştirme sporcusunda akut miyokart enfarktüsü ve renal enfarktüs. Türk Kardiyoloji Derneği Arşivi, Cilt: 38 - Sayı: 4, 275–278. https://ajindex.com/articles/633257

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Huang CC, Lo HC, Huang HH, Kao WF, Yen DH, Wang LM, et al. ED presentations of acute renal infarction. Am J Emerg Med 2007;25:164-9
  2. Huang CC, Chen WL, Chen JH, Wu YL, Shiao CJ. Clinical characteristics of renal infarction in an Asian population. Ann Acad Med Singapore 2008;37:416 20
  3. Hazanov N, Somin M, Attali M, Beilinson N, Thaler M, Mouallem M, et al. Acute renal embolism. Forty-four cases of renal infarction in patients with atrial fibrillation. Medicine 2004;83:292-9
  4. Melchert RB, Welder AA. Cardiovascular effects of androgenic-anabolic steroids. Med Sci Sports Exerc 1995; 27:1252-62
  5. Ebenbichler CF, Sturm W, Gänzer H, Bodner J, Mangweth B, Ritsch A, et al. Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids. Atherosclerosis 2001;158:483-90
  6. Ajayi AA, Mathur R, Halushka PV. Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses. Circulation 1995;91:2742-7
  7. Ebenbichler CF, Kaser S, Bodner J, Gander R, Lechleitner M, Herold M, et al. Hyperhomocysteinemia in bodybuilders taking anabolic steroids. Eur J Intern Med 2001;12:43-7
  8. Ferenchick GS, Hirokawa S, Mammen EF, Schwartz KA. Anabolic-androgenic steroid abuse in weight lifters: evidence for activation of the hemostatic system. Am J Hematol 1995;49:282-8
  9. Ferenchick G, Schwartz D, Ball M, Schwartz K. Androgenic-anabolic steroid abuse and platelet aggregation: a pilot study in weight lifters. Am J Med Sci 1992;303:78-82
  10. Fisher M, Appleby M, Rittoo D, Cotter L. Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids. Br J Clin Pract 1996; 50:222-3.